Cyclic isothiourea derivatives as cxcr4 modulators
US-2024018125-A1 · Jan 18, 2024 · US
This page is not indexed by search engines while we improve data quality.
Ermium Therapeutics — Human Necessities
Ermium Therapeutics holds 1 patent in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Ermium Therapeutics |
| Technology | Human Necessities |
| Patents in slice | 1 |
| Recent patents in slice | 1 |
| First year | 2024 |
| Last year | 2024 |
Representative patents
Notable publications linking Ermium Therapeutics to Human Necessities.
Cyclic isothiourea derivatives as cxcr4 modulators
US-2024018125-A1 · Jan 18, 2024 · US
Cyclic isothiourea derivatives as cxcr4 modulators
US-2024018125-A1 · Jan 18, 2024 · US
Cyclic isothiourea derivatives as cxcr4 modulators
US-2024018125-A1 · Jan 18, 2024 · US
Cyclic isothiourea derivatives as cxcr4 modulators
US-2024018125-A1 · Jan 18, 2024 · US
Recent filings
Latest patents from Ermium Therapeutics in Human Necessities.
Cyclic isothiourea derivatives as cxcr4 modulators
US-2024018125-A1 · Jan 18, 2024 · US
Cyclic isothiourea derivatives as cxcr4 modulators
US-2024018125-A1 · Jan 18, 2024 · US
Cyclic isothiourea derivatives as cxcr4 modulators
US-2024018125-A1 · Jan 18, 2024 · US
Cyclic isothiourea derivatives as cxcr4 modulators
US-2024018125-A1 · Jan 18, 2024 · US
Cyclic isothiourea derivatives as cxcr4 modulators
US-2024018125-A1 · Jan 18, 2024 · US
Related pages
Navigate to parent entity pages.